Biofilm formation mechanisms and targets for developing antibiofilm agents

Future Medicinal Chemistry

Volumn 7, Issue 4, 2015, Pages 493-512

  Rabin, Nira ^a   Zheng, Yue ^a   Opoku Temeng, Clement ^a   Du, Yixuan ^a   Bonsu, Eric ^b   Sintim, Herman O ^a  

^a Bldg 142   (United States)

^b BOWIE STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOFILM AGENT; ANTIBIOTIC AGENT; DINUCLEOTIDE; DNA; EXOPOLYSACCHARIDE; EXTRACELLULAR DNA; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT;

BIOFILM; CARDIAC VALVE INFECTION; CARDIOVASCULAR INFECTION; CHRONIC WOUND; CYSTIC FIBROSIS; EXTRACELLULAR MATRIX; EXTRACELLULAR POLYMERIC SUBSTANCE MATRIX; GENE EXPRESSION; GROWTH RATE; HORIZONTAL GENE TRANSFER; HUMAN; IMMUNE SYSTEM; NONHUMAN; PERIPROSTHETIC JOINT INFECTION; PRIORITY JOURNAL; QUORUM SENSING; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; TOOTH PLAQUE; URINARY TRACT INFECTION; ANTIBIOTIC RESISTANCE; BACTERIAL INFECTION; CHEMISTRY; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; MICROBIOLOGY; SYNTHESIS;

ANTI-INFECTIVE AGENTS; BACTERIAL INFECTIONS; BIOFILMS; DRUG RESISTANCE, MICROBIAL; HUMANS; QUORUM SENSING;

EID: 84928168940     PISSN: 17568919     EISSN: 17568927     Source Type: Journal    
DOI: 10.4155/fmc.15.6     Document Type: Review

References (158)

1. Henrici AT. Studies of freshwater bacteria: I. A direct microscopic technique. J. Bacteriol. 25(3), 277-287 (1933).
2. Heukelekian H, Heller A. Relation between food concentration and surface for bacterial growth. J. Bacteriol. 40 (4), 547-558 (1940).
3. Hoiby N, Flensborg E, Beck B, Friis B, Jacobsen S, Jacobsen L. Pseudomonas aeruginosa infection in cystic fibrosis. Diagnostic and prognostic significance of Pseudomonas aeruginosa precipitins determined by means of crossed immunoelectrophoresis. Scand. J. Respir. Dis. 58(2), 65-79 (1977).
4. Costerton JW, Geesey GG, Cheng KJ. How bacteria stick. Sci. Am. 238(1), 86-95 (1978).
5. Deligianni E, Pattison S, Berrar D et al. Pseudomonas aeruginosa cystic fibrosis isolates of similar RAPD genotype exhibit diversity in biofilm forming ability in vitro. BMC Microbiol. 10, 38 (2010).
6. Ludecke C, Jandt KD, Siegismund D et al. Reproducible biofilm cultivation of chemostat-grown Escherichia coli and investigation of bacterial adhesion on biomaterials using a non-constant-depth film fermenter. PLoS One 9(1), e84837 (2014).
7. Thurlow LR, Hanke ML, Fritz T et al. Staphylococcus aureus biofilms prevent macrophage phagocytosis and attenuate inflammation in vivo. J. Immunol. 186(11), 6585-6596 (2011).
8. Pammi M, Liang R, Hicks JM, Barrish J, Versalovic J. Farnesol decreases biofilms of Staphylococcus epidermidis and exhibits synergy with nafcillin and vancomycin. Pediatr. Res. 70 (6), 578-583 (2011).
9. Annous BA, Fratamico PM, Smith JL. Scientific status summary. J. Food Sci. 74(1), R24-R37 (2009).
10. Metwalli KH, Khan SA, Krom BP, Jabra-Rizk MA. Streptococcus mutans Candida albicans and the human mouth: a sticky situation. PLoS Pathog. 9 (10), e1003616 (2013).
11. Flemming HC, Neu TR, Wozniak DJ. The EPS matrix: the "house of biofilm cells". J. Bacteriol. 189(22), 7945-7947 (2007).
12. Zhang X, Bishop PL, Kupferle MJ. Measurement of polysaccharides and proteins in biofilm extracellular polymers. Water Sci. Technol. 37 (45), 345-348 (1998).
13. Nwodo UU, Green E, Okoh AI. Bacterial exopolysaccharides: functionality and prospects. Int. J. Mol. Sci. 13(11), 14002-14015 (2012).
14. Dawson LF, Valiente E, Faulds-Pain A, Donahue EH, Wren BW. Characterisation of clostridium difficile biofilm formation, a role for Spo0A. PLoS One 7(12), e50527 (2012).
15. Bales PM, Renke EM, May SL, Shen Y, Nelson DC. Purification and characterization of biofilm-associated EPS exopolysaccharides from ESKAPE organisms and other pathogens. PLoS One 8(6), e67950 (2013).
16. Prigent-Combaret C, Vidal O, Dorel C, Lejeune P. Abiotic surface sensing and biofilm-dependent regulation of gene expression in Escherichia coli. J. Bacteriol. 181(19), 5993-6002 (1999).
17. Davies DG, Geesey GG. Regulation of the alginate biosynthesis gene algC in Pseudomonas aeruginosa during biofilm development in continuous culture. Appl. Environ. Microbiol. 61(3), 860-867 (1995).
18. Grant WD, Sutherland IW, Wilkinson JF. Exopolysaccharide colanic acid and its occurrence in the Enterobacteriaceae. J. Bacteriol. 100(3), 1187-1193 (1969).
19. Stevenson G, Andrianopoulos K, Hobbs M, Reeves PR. Organization of the Escherichia coli K-12 gene cluster responsible for production of the extracellular polysaccharide colanic acid. J. Bacteriol. 178(16), 4885-4893 (1996).
20. Reid AN, Whitfield C. Functional analysis of conserved gene products involved in assembly of Escherichia coli capsules and exopolysaccharides: evidence for molecular recognition between Wza and Wzc for colanic acid biosynthesis. J. Bacteriol. 187(15), 5470-5481 (2005).
21. Danese PN, Pratt LA, Kolter R. Exopolysaccharide production is required for development of Escherichia coli K-12 biofilm architecture. J. Bacteriol. 182(12), 3593-3596 (2000).
22. Friedman L, Kolter R. Genes involved in matrix formation in Pseudomonas aeruginosa PA14 biofilms. Mol. Microbiol. 51(3), 675-690 (2004).
23. Friedman L, Kolter R. Two genetic loci produce distinct carbohydrate-rich structural components of the Pseudomonas aeruginosa biofilm matrix. J. Bacteriol. 186(14), 4457-4465 (2004).
24. Jackson KD, Starkey M, Kremer S, Parsek MR, Wozniak DJ. Identification of psl, a locus encoding a potential exopolysaccharide that is essential for Pseudomonas aeruginosa PAO1 biofilm formation. J. Bacteriol. 186(14), 4466-4475 (2004).
25. May TB, Shinabarger D, Maharaj R et al. Alginate synthesis by Pseudomonas aeruginosa : a key pathogenic factor in chronic pulmonary infections of cystic fibrosis patients. Clin. Microbiol. Rev. 4(2), 191-206 (1991).
26. Hodges NA, Gordon CA. Protection of Pseudomonas aeruginosa against ciprofloxacin and beta-lactams by homologous alginate. Antimicrob. Agents Chemother. 35(11), 2450-2452 (1991).
27. Simpson JA, Smith SE, Dean RT. Alginate inhibition of the uptake of Pseudomonas aeruginosa by macrophages. J. Gen. Microbiol. 134(1), 29-36 (1988).
28. Ma L, Wang J, Wang S et al. Synthesis of multiple Pseudomonas aeruginosa biofilm matrix exopolysaccharides is post-transcriptionally regulated. Environ. Microbiol. 14(8), 1995-2005 (2012).
29. Coyne MJ, Russell KS, Coyle CL, Goldberg JB. The Pseudomonas aeruginosa algC gene encodes phosphoglucomutase, required for the synthesis of a complete lipopolysaccharide core. J. Bacteriol. 176(12), 3500-3507 (1994).
30. Colvin KM, Irie Y, Tart CS et al. The Pel and Psl polysaccharides provide Pseudomonas aeruginosa structural redundancy within the biofilm matrix. Environ. Microbiol. 14(8), 1913-1928 (2012).
31. Franklin MJ, Nivens DE, Weadge JT, Howell PL. Biosynthesis of the Pseudomonas aeruginosa extracellular polysaccharides, alginate, Pel, and Psl. Front. Microbiol. 2, 167 (2011).
32. Gacesa P. Bacterial alginate biosynthesis - recent progress and future prospects. Microbiology 144 (5), 1133-1143 (1998).
33. Stokke BT, Draget KI, SmidsrØd O, Yuguchi Y, Urakawa H, Kajiwara K. Small-angle x-ray scattering and rheological characterization of alginate Gels. 1. Ca-Alginate Gels. Macromolecules 33(5), 1853-1863 (2000).
34. Mack D, Fischer W, Krokotsch A et al. The intercellular adhesin involved in biofilm accumulation of Staphylococcus epidermidis is a linear beta-1,6-linked glucosaminoglycan: purification and structural analysis. J. Bacteriol. 178(1), 175-183 (1996).
35. Cue DR, Lei MG, Lee C. Genetic regulation of the intercellular adhesion locus in staphylococci. Front. Cell. Infect. Microbiol. 2, 38 (2012).
36. Stanley NR, Lazazzera BA. Defining the genetic differences between wild and domestic strains of Bacillus subtilis that affect poly- γ-DL -glutamic acid production and biofilm formation. Mol. Microbiol. 57(4), 1143-1158 (2005).
37. Branda SS, Chu F, Kearns DB, Losick R, Kolter R. A major protein component of the Bacillus subtilis biofilm matrix. Mol. Microbiol. 59 (4), 1229-1238 (2006).
38. FrØlund B, Palmgren R, Keiding K, Nielsen PH. Extraction of extracellular polymers from activated sludge using a cation exchange resin. Water Res. 30(8), 1749-1758 (1996).
39. Lynch DJ, Fountain TL, Mazurkiewicz JE, Banas JA. Glucan-binding proteins are essential for shaping Streptococcus mutans biofilm architecture. FEMS Microbiol. Lett. 268(2), 158-165 (2007).
40. Dueholm MS, Søndergaard MT, Nilsson M et al. Expression of Fap amyloids in Pseudomonas aeruginosa, P. fluorescens, and P. putida results in aggregation and increased biofilm formation. Microbiologyopen 2(3), 365-382 (2013).
41. Romero D, Aguilar C, Losick R, Kolter R. Amyloid fibers provide structural integrity to Bacillus subtilis biofilms. Proc. Natl. Acad. Sci. USA 107(5), 2230-2234 (2010).
42. Cucarella C, Solano C, Valle J, Amorena B, Lasa I, Penadés JR. Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J. Bacteriol. 183(9), 2888-2896 (2001).
43. Toledo-Arana A, Valle J, Solano C et al. The enterococcal surface protein, Esp, is involved in Enterococcus faecalis biofilm formation. Appl. Environ. Microbiol. 67(10), 4538-4545 (2001).
44. Lasa I, Penadés JR. Bap: a family of surface proteins involved in biofilm formation. Res. Microbiol. 157(2), 99-107 (2006).
45. Mora P, Rosconi F, Franco Fraguas L, Castro-Sowinski S. Azospirillum brasilense Sp7 produces an outer-membrane lectin that specifically binds to surface-exposed extracellular polysaccharide produced by the bacterium. Arch. Microbiol. 189(5), 519-524 (2008).
46. Diggle SP, Stacey RE, Dodd C, Cámara M, Williams P, Winzer K. The galactophilic lectin, LecA, contributes to biofilm development in Pseudomonas aeruginosa. Environ. Microbiol. 8(6), 1095-1104 (2006).
47. Tielker D, Hacker S, Loris R et al. Pseudomonas aeruginosa lectin LecB is located in the outer membrane and is involved in biofilm formation. Microbiology 151(5), 1313-1323 (2005).
48. Zhang X, Bishop PL. Biodegradability of biofilm extracellular polymeric substances. Chemosphere 50(1), 63-69 (2003).
49. Kaplan JB, Velliyagounder K, Ragunath C et al. Genes involved in the synthesis and degradation of matrix polysaccharide in Actinobacillus actinomycetemcomitans and Actinobacillus pleuropneumoniae biofilms. J. Bacteriol. 186(24), 8213-8220 (2004).
50. Whitchurch CB, Tolker-Nielsen T, Ragas PC, Mattick JS. Extracellular DNA required for bacterial biofilm formation. Science 295(5559), 1487 (2002).
51. Hamilton HL, Domínguez NM, Schwartz KJ, Hackett KT, Dillard JP. Neisseria gonorrhoeae secretes chromosomal DNA via a novel type IV secretion system. Mol. Microbiol. 55(6), 1704-1721 (2005).
52. Das T, Sharma PK, Busscher HJ, van der Mei HC, Krom BP. Role of extracellular DNA in initial bacterial adhesion and surface aggregation. Appl. Environ. Microbiol. 76(10), 3405-3408 (2010).
53. Gloag ES, Turnbull L, Huang A et al. Self-organization of bacterial biofilms is facilitated by extracellular DNA. Proc. Natl. Acad. Sci. USA 110(28), 11541-11546 (2013).
54. Lewenza S. Extracellular DNA-induced antimicrobial peptide resistance mechanisms in Pseudomonas aeruginosa. Front. Microbiol. 4, 21 (2013).
55. Mulcahy H, Charron-Mazenod L, Lewenza S. Extracellular DNA chelates cations and induces antibiotic resistance in Pseudomonas aeruginosa biofilms. PLoS Pathog. 4(11), e1000213 (2008).
56. Johnson L, Horsman SR, Charron-Mazenod L et al. Extracellular DNA-induced antimicrobial peptide resistance in Salmonella enterica serovar Typhimurium. BMC Microbiol. 13, 115 (2013).
57. Doroshenko N, Tseng BS, Howlin RP et al. Extracellular DNA impedes the transport of vancomycin in Staphylococcus epidermidis biofilms pre-exposed to sub-inhibitory concentrations of vancomycin. Antimicrob. Agents Chemother.58(12), 7273-7282 (2014).
58. Otto M. Staphylococcus epidermidis Pathogenesis. Methods Mol. Biol. 1106, 17-31 (2014).
59. Barnes AMT, Ballering KS, Leibman RS, Wells CL, Dunny GM. Enterococcus faecalis produces abundant extracellular structures containing DNA in the absence of cell lysis during early biofilm formation. MBio. 3(4), e00193-12 (2012).
60. Jefferson KK. What drives bacteria to produce a biofilm? FEMS Microbiol. Lett. 236(2), 163-173 (2004).
61. Rasmussen TB, Givskov M. Quorum-sensing inhibitors as anti-pathogenic drugs. Int. J. Med. Microbiol. 296(23), 149-161 (2006).
62. Hausner M, Wuertz S. High rates of conjugation in bacterial biofilms as determined by quantitative in situ analysis. Appl. Environ. Microbiol. 65(8), 3710-3713 (1999).
63. Palmer J, Flint S, Brooks J. Bacterial cell attachment, the beginning of a biofilm. J. Ind. Microbiol. Biotechnol. 34(9), 577-588 (2007).
64. Renner LD, Weibel DB. Physicochemical regulation of biofilm formation. MRS Bull. 36(5), 347-355 (2011).
65. Sutherland I. Biofilm exopolysaccharides: a strong and sticky framework. Microbiology 147(1), 3-9 (2001).
66. O'Toole GA, Kolter R. Flagellar and twitching motility are necessary for Pseudomonas aeruginosa biofilm development. Mol. Microbiol. 30(2), 295-304 (1998).
67. Otto M. Staphylococcal biofilms. Curr. Top. Microbiol. Immunol. 207-228 (2008).
68. Heilmann C, Hussain M, Peters G, Götz F. Evidence for autolysin-mediated primary attachment of Staphylococcus epidermidis to a polystyrene surface. Mol. Microbiol. 24(5), 1013-1024 (1997).
69. Davies DG, Chakrabarty AM, Geesey GG. Exopolysaccharide production in biofilms: substratum activation of alginate gene expression by Pseudomonas aeruginosa. Appl. Environ. Microbiol. 59(4), 1181-1186 (1993).
70. Garrett ES, Perlegas D, Wozniak DJ. Negative control of flagellum synthesis in Pseudomonas aeruginosa is modulated by the alternative sigma factor AlgT (AlgU). J. Bacteriol. 181(23), 7401-7404 (1999).
71. Hall MR, McGillicuddy E, Kaplan LJ. Biofilm: basic principles, pathophysiology, and implications for clinicians. Surg. Infect. (Larchmt.) 15(1), 1-7 (2014).
72. Fux CA, Costerton JW, Stewart PS, Stoodley P. Survival strategies of infectious biofilms. Trends Microbiol. 13(1), 34-40 (2005).
73. Davies D. Understanding biofilm resistance to antibacterial agents. Nat. Rev. Drug Discov. 2(2), 114-122 (2003).
74. Lyczak JB, Cannon CL, Pier GB. Lung infections associated with cystic fibrosis. Clin. Microbiol. Rev. 15(2), 194-222 (2002).
75. Pedersen SS, Koch C, HØiby N, Rosendal K. An epidemic spread of multiresistant Pseudomonas aeruginosa in a cystic fibrosis centre. J. Antimicrob. Chemother. 17(4), 505-516 (1986).
76. Jones AM, Govan JR, Doherty CJ et al. Spread of a multiresistant strain of Pseudomonas aeruginosa in an adult cystic fibrosis clinic. Lancet 358(9281), 557-558 (2001).
77. Römling U, Fiedler B, Bosshammer J et al. Epidemiology of chronic Pseudomonas aeruginosa infections in cystic fibrosis. J. Infect. Dis. 170(6), 1616-1621 (1994).
78. Costerton JW, Stewart PS, Greenberg EP. Bacterial biofilms: a common cause of persistent infections. Science 284(5418), 1318-1322 (1999).
79. Moreau-Marquis S, Stanton BA, O'Toole GA. Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway. Pulm. Pharmacol. Ther. 21(4), 595-599 (2008).
80. Pedersen SS, H ∅ iby N, Espersen F, Koch C. Role of alginate in infection with mucoid Pseudomonas aeruginosa in cystic fibrosis. Thorax 47(1), 6-13 (1992).
81. Hojo K, Nagaoka S, Ohshima T, Maeda N. Bacterial interactions in dental biofilm development. J. Dent. Res. 88(11), 982-990 (2009).
82. Marsh PD. Dental plaque as a microbial biofilm. Caries Res. 38(3), 204-211 (2004).
83. Marsh PD. Dental plaque as a biofilm and a microbial community - implications for health and disease. BMC Oral Health 6(Suppl 1), 14 (2006).
84. Zaura E, Keijser B, Huse S, Crielaard W. Defining the healthy "core microbiome" of oral microbial communities. BMC Microbiol. 9(1), 259 (2009).
85. Li J, Helmerhorst EJ, Leone CW et al. Identification of early microbial colonizers in human dental biofilm. J. Appl. Microbiol. 97(6), 1311-1318 (2004).
86. Marquis RE. Oxygen metabolism, oxidative stress and acid-base physiology of dental plaque biofilms. J. Ind. Microbiol. 15(3), 198-207 (1995).
87. Sbordone L, Bortolaia C. Oral microbial biofilms and plaque-related diseases: microbial communities and their role in the shift from oral health to disease. Clin. Oral Investig. 7(4), 181-188 (2003).
88. Dige I, Nilsson H, Kilian M, Nyvad B. In situ identification of streptococci and other bacteria in initial dental biofilm by confocal laser scanning microscopy and fluorescence in situ hybridization. Eur. J. Oral Sci. 115(6), 459-467 (2007).
89. Dige I, Raarup MK, Nyengaard JR, Kilian M, Nyvad B. Actinomyces naeslundii in initial dental biofilm formation. Microbiology 155(7), 2116-2126 (2009).
90. Kolenbrander PE, Palmer RJ Jr, Periasamy S, Jakubovics NS. Oral multispecies biofilm development and the key role of cell-cell distance. Nat. Rev. Micro. 8(7), 471-480 (2010).
91. Hardie KR, Heurlier K. Establishing bacterial communities by 'word of mouth': LuxS and autoinducer 2 in biofilm development. Nat. Rev. Micro. 6(8), 635-643 (2008).
92. Bassler BL, Greenberg EP, Stevens AM. Cross-species induction of luminescence in the quorum-sensing bacterium Vibrio harveyi. J. Bacteriol. 179(12), 4043-4045 (1997).
93. James GA, Swogger E, Wolcott R et al. Biofilms in chronic wounds. Wound Repair Regen. 16(1), 37-44 (2008).
94. Tenke P, Kovacs B, Jäckel M, Nagy E. The role of biofilm infection in urology. World J. Urol. 24(1), 13-20 (2006).
95. Jacobsen SM, Stickler DJ, Mobley HL, Shirtliff ME. Complicated catheter-associated urinary tract infections due to Escherichia coli and Proteus mirabilis. Clin. Microbiol. Rev. 21(1), 26-59 (2008).
96. Matthews PC, Berendt AR, McNally MA, Byren I. Diagnosis and management of prosthetic joint infection. BMJ 338, b1773 (2009).
97. Trampuz A, Zimmerli W. Prosthetic joint infections: update in diagnosis and treatment. Swiss Med. Wkly. 135(1718), 243-251 (2005).
98. Khardori N, Yassien M. Biofilms in device-related infections. J. Ind. Microbiol. 15(3), 141-147 (1995).
99. Costerton JW, Lewandowski Z, Caldwell DE, Korber DR, Lappin-Scott HM. Microbial Biofilms. Annu. Rev. Microbiol. 49(1), 711-745 (1995).
100. Nickel JC, Ruseska I, Wright JB, Costerton JW. Tobramycin resistance of Pseudomonas aeruginosa cells growing as a biofilm on urinary catheter material. Antimicrob. Agents Chemother. 27(4), 619-624 (1985).
101. Luppens SB, Reij MW, van der Heijden RW, Rombouts FM, Abee T. Development of a standard test to assess the resistance of Staphylococcus aureus biofilm cells to disinfectants. Appl. Environ. Microbiol. 68(9), 4194-4200 (2002).
102. Suci PA, Mittelman MW, Yu FP, Geesey GG. Investigation of ciprofloxacin penetration into Pseudomonas aeruginosa biofilms. Antimicrob. Agents Chemother. 38(9), 2125-2133 (1994).
103. Anderl JN, Franklin MJ, Stewart PS. Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin. Antimicrob. Agents Chemother. 44(7), 1818-1824 (2000).
104. Savage VJ, Chopra I, O'Neill AJ. Staphylococcus aureus biofilms promote horizontal transfer of antibiotic resistance. Antimicrob. Agents Chemother. 57(4), 1968-1970 (2013).
105. Ashby MJ, Neale JE, Knott SJ, Critchley IA. Effect of antibiotics on non-growing planktonic cells and biofilms of Escherichia coli. J. Antimicrob. Chemother. 33(3), 443-452 (1994).
106. Lewis K. Persister cells, dormancy and infectious disease. Nat. Rev. Microbiol. 5(1), 48-56 (2007).
107. Keren I, Shah D, Spoering A, Kaldalu N, Lewis K. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186(24), 8172-8180 (2004).
108. Zhang L, Mah TF. Involvement of a novel efflux system in biofilm-specific resistance to antibiotics. J. Bacteriol. 190(13), 4447-4452 (2008).
109. Leid JG, Willson CJ, Shirtliff ME, Hassett DJ, Parsek MR, Jeffers AK. The exopolysaccharide alginate protects Pseudomonas aeruginosa biofilm bacteria from IFN-gamma- mediated macrophage killing. J. Immunol. 175(11), 7512-7518 (2005).
110. Lyon GJ, Muir TW. Chemical signaling among bacteria and its inhibition. Chem. Biol. 10(11), 1007-1021 (2003).
111. West SA, Winzer K, Gardner A, Diggle SP. Quorum sensing and the confusion about diffusion. Trends Microbiol. 20(12), 586-594 (2012).
112. Camilli A, Bassler BL. Bacterial small-molecule signaling pathways. Science 311(5764), 1113-1116 (2006).
113. Rezzonico F, Duffy B. Lack of genomic evidence of AI-2 receptors suggests a non-quorum sensing role for luxS in most bacteria. BMC Microbiol. 8, 154 (2008).
114. Miller MB, Bassler BL. Quorum sensing in bacteria. Annu. Rev. Microbiol. 55(1), 165-199 (2001).
115. Romeo T, Irie Y, Parsek MR. Quorum sensing and microbial biofilms. Curr. Top. Microbiol. Immunol. 67-84 (2008).
116. Allesen-Holm M, Barken KB, Yang L et al. A characterization of DNA release in Pseudomonas aeruginosa cultures and biofilms. Mol. Microbiol. 59(4), 1114-1128 (2006).
117. Sakuragi Y, Kolter R. Quorum-sensing regulation of the biofilm matrix genes (pel) of Pseudomonas aeruginosa. J. Bacteriol. 189(14), 5383-5386 (2007).
118. Boles BR, Horswill AR. Agr-mediated dispersal of Staphylococcus aureus biofilms. PLoS Pathog. 4(4), e1000052 (2008).
119. Novick RP, Geisinger E. Quorum sensing in staphylococci. Annu. Rev. Genet. 42, 541-564 (2008).
120. López D, Fischbach MA, Chu F, Losick R, Kolter R. Structurally diverse natural products that cause potassium leakage trigger multicellularity in Bacillus subtilis. Proc. Natl. Acad. Sci. USA 106(1), 280-285 (2009).
121. Weinhouse H, Sapir S, Amikam D et al. c-di-GMP-binding protein, a new factor regulating cellulose synthesis in Acetobacter xylinum. FEBS Lett. 416(2), 207-211 (1997).
122. Ross P, Mayer R, Weinhouse H et al. The cyclic diguanylic acid regulatory system of cellulose synthesis in Acetobacter xylinum c hemical synthesis and biological activity of cyclic nucleotide dimer, trimer, and phosphothioate derivatives. J. Biol. Chem. 265(31), 18933-18943 (1990).
123. Kalia D, Merey G, Nakayama S et al. Nucleotide, c-di-GMP, c-di-AMP, cGMP, cAMP, (p)ppGpp signaling in bacteria and implications in pathogenesis. Chem. Soc. Rev. 42(1), 305-341 (2013).
124. Ross P, Weinhouse H, Aloni Y et al. Regulation of cellulose synthesis in Acetobacter xylinum by cyclic diguanylic acid. Nature 325(6101), 279-281 (1987).
125. Ryjenkov DA, Tarutina M, Moskvin OV, Gomelsky M. Cyclic diguanylate is a ubiquitous signaling molecule in bacteria: insights into biochemistry of the GGDEF protein domain. J. Bacteriol. 187(5), 1792-1798 (2005).
126. Paul R, Weiser S, Amiot NC et al. Cell cycle-dependent dynamic localization of a bacterial response regulator with a novel di-guanylate cyclase output domain. Genes Dev. 18(6), 715-727 (2004).
127. Tischler AD, Camilli A. Cyclic diguanylate regulates Vibrio cholerae virulence gene expression. Infect. Immun. 73(9), 5873-5882 (2005).
128. Boyd CD, O'Toole GA. Second messenger regulation of biofilm formation: breakthroughs in understanding c-di-GMP effector systems. Annu. Rev. Cell Dev. Biol. 28, 439-462 (2012).
129. Newell PD, Monds RD, O'Toole GA. LapD is a bis-(3′,5′)- cyclic dimeric GMP-binding protein that regulates surface attachment by Pseudomonas fluorescens Pf0-1. Proc. Natl Acad. Sci. USA 106(9), 3461-3466 (2009).
130. Newell PD, Boyd CD, Sondermann H, O'Toole GA. A c-di-GMP effector system controls cell adhesion by inside-out signaling and surface protein cleavage. PLoS Biol. 9(2), e1000587 (2011).
131. Monds RD, Newell PD, Gross RH, O'Toole GA. Phosphate-dependent modulation of c-di-GMP levels regulates Pseudomonas fluorescens Pf0-1 biofilm formation by controlling secretion of the adhesin LapA. Mol. Microbiol. 63(3), 656-679 (2007).
132. Ryjenkov DA, Simm R, Römling U, Gomelsky M. The PilZ domain is a receptor for the second messenger c-di-GMP: the PilZ domain protein YcgR controls motility in enterobacteria. J. Biol. Chem. 281(41), 30310-30314 (2006).
133. Boehm A, Kaiser M, Li H et al. Second messenger-mediated adjustment of bacterial swimming velocity. Cell 141(1), 107-116 (2010).
134. Paul K, Nieto V, Carlquist WC, Blair DF, Harshey RM. The c-di-GMP binding protein YcgR controls flagellar motor direction and speed to affect chemotaxis by a "backstop brake" mechanism. Mol. Cell 38(1), 128-139 (2010).
135. Martinez-Wilson HF, Tamayo R, Tischler AD, Lazinski DW, Camilli A. The Vibrio cholerae hybrid sensor kinase VieS contributes to motility and biofilm regulation by altering the cyclic diguanylate level. J. Bacteriol. 190(19), 6439-6447 (2008).
136. Tamayo R, Tischler AD, Camilli A. The EAL Domain protein VieA is a cyclic diguanylate phosphodiesterase. J. Biol. Chem. 280(39), 33324-33330 (2005).
137. Simm R, Morr M, Kader A, Nimtz M, Römling U. GGDEF and EAL domains inversely regulate cyclic di- GMP levels and transition from sessility to motility. Mol. Microbiol. 53(4), 1123-1134 (2004).
138. Kirillina O, Fetherston JD, Bobrov AG, Abney J, Perry RD. HmsP, a putative phosphodiesterase, and HmsT, a putative diguanylate cyclase, control Hms-dependent biofilm formation in Yersinia pestis. Mol. Microbiol. 54(1), 75-88 (2004).
139. Wilksch JJ, Yang J, Clements A et al. MrkH, a novel c-di-GMP-dependent transcriptional activator, controls Klebsiella pneumoniae biofilm formation by regulating type 3 fimbriae expression. PLoS Pathog. 7(8), e1002204 (2011).
140. Carlson HK, Vance RE, Marletta MA. H-NOX regulation of c-di-GMP metabolism and biofilm formation in Legionella pneumophila. Mol. Microbiol. 77(4), 930-942 (2010).
141. Nakhamchik A, Wilde C, Rowe-Magnus DA. Cyclic-di- GMP regulates extracellular polysaccharide production, biofilm formation, and rugose colony development by Vibrio vulnificus. Appl. Environ. Microbiol. 74(13), 4199-4209 (2008).
142. Romeo T, Gong M, Liu MY, Brun-Zinkernagel AM. Identification and molecular characterization of csrA, a pleiotropic gene from Escherichia coli that affects glycogen biosynthesis, gluconeogenesis, cell size, and surface properties. J. Bacteriol. 175(15), 4744-4755 (1993).
143. Liu MY, Gui G, Wei B et al. The RNA molecule CsrB binds to the global regulatory protein CsrA and antagonizes its activity in Escherichia coli. J. Biol. Chem. 272(28), 17502-17510 (1997).
144. Jackson DW, Suzuki K, Oakford L, Simecka JW, Hart ME, Romeo T. Biofilm formation and dispersal under the influence of the global regulator CsrA of Escherichia coli. J. Bacteriol. 184(1), 290-301 (2002).
145. Ventre I, Goodman AL, Vallet-Gely I et al. Multiple sensors control reciprocal expression of Pseudomonas aeruginosa regulatory RNA and virulence genes. Proc. Natl Acad. Sci. USA 103(1), 171-176 (2006).
146. Kay E, Humair B, Dénervaud V et al. Two GacA-dependent small RNAs modulate the quorum-sensing response in Pseudomonas aeruginosa. J. Bacteriol. 188(16), 6026-6033 (2006).
147. Jimenez PN, Koch G, Thompson JA, Xavier KB, Cool RH, Quax WJ. The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev. 76(1), 46-65 (2012).
148. Babitzke P, Romeo T. CsrB sRNA family: sequestration of RNA-binding regulatory proteins. Curr. Opin. Microbiol. 10(2), 156-163 (2007).
149. Ogasawara H, Yamamoto K, Ishihama A. Role of the biofilm master regulator CsgD in cross-regulation between biofilm formation and flagellar synthesis. J. Bacteriol. 193(10), 2587-2597 (2011).
150. Mika F, Hengge R. Small RNAs in the control of RpoS, CsgD, and biofilm architecture of Escherichia coli. RNA Biol. 11(5), 494-507 (2014).
151. Chambers JR, Sauer K. Small RNAs and their role in biofilm formation. Trends Microbiol. 21(1), 39-49 (2013).
152. Dalton T, Dowd SE, Wolcott RD et al. An in vivo polymicrobial biofilm wound infection model to study interspecies interactions. PLoS One 6(11), e27317 (2011).
153. Hoffmann N, Rasmussen TB, Jensen PØ et al. Novel mouse model of chronic Pseudomonas aeruginosa lung infection mimicking cystic fibrosis. Infect. Immun. 73(4), 2504-2514 (2005).
154. Buret A, Ward KH, Olson ME, Costerton JW. An in vivo model to study the pathobiology of infectious biofilms on biomaterial surfaces. J. Biomed. Mater. Res. 25(7), 865-874 (1991).
155. Chauhan A, Lebeaux D, Decante B et al. A rat model of central venous catheter to study establishment of long-term bacterial biofilm and related acute and chronic infections. PLoS One 7(5), e37281 (2012).
156. Cole SJ, Records AR, Orr MW, Linden SB, Lee VT. Catheter-associated urinary tract infection by Pseudomonas aeruginosa is mediated by exopolysaccharide independent biofilms. Infect. Immun. 82(5), 2048-2058 (2014).
157. Watters C, DeLeon K, Trivedi U et al. Pseudomonas aeruginosa biofilms perturb wound resolution and antibiotic tolerance in diabetic mice. Med. Microbiol. Immunol. 202(2), 131-141 (2013).
158. Bjarnsholt T, Jensen PØ, Fiandaca MJ et al. Pseudomonas aeruginosa biofilms in the respiratory tract of cystic fibrosis patients. Pediatr. Pulmonol. 44(6), 547-558 (2009).